• Magnesium mono-preparation for parenteral, intramuscular or intravenous administration
• Against cramps and muscle tension
• Gynaecology: for pre-eclampsia, eclampsia, premature labour
• Contains only physiological substances

Package sizes:

Magnesium-Diasporal® 2 mmol injectable solution

• 5 x 5 ml ampoules
• 50 x 5 ml ampoules

Magnesium-Diasporal® 4 mmol injectable solution

• 5 x 2 ml ampoules
• 50 x 2 ml ampoules

Magnesium-Diasporal® 2 mmol injectable solution
1 ampoule (5 ml) injection solution contains the active ingredient:

• Magnesium sulphate x 7 H2O 493.0 mg
• Magnesium content: 48.61 mg = 2 mmol = 4 mval

Magnesium-Diasporal® 4 mmol injectable solution
1 ampoule (2 ml) injection solution contains the active ingredient:

• Magnesium sulphate x 7 H2O 986.0 mg
• Magnesium content: 97.22 mg = 4 mmol = 8 mval

Other ingredients: water for injection purposes.

Proven magnesium deficiency causing muscle activity disorders (neuromuscular disorders, calf cramps). Details of other gynaecological therapeutic indications are provided in the package information leaflet. For risks and side-effects please read the package leaflet and ask your doctor or pharmacist.

The dosage depends on the indication and on the magnesium serum level. Please consult your doctor.

Magnesium-Diasporal® 2 mmol/4 mmol, injection solution

(active ingredient: magnesium sulphate). Therapeutic indications: proven magnesium deficiency causing muscle activity disorders (neuromuscular disorders, calf cramps), eclampsia, pre-eclampsia, premature labour. Magnesium sulphate therapy is only indicated if the magnesium serum level is below the normal values (0.8 - 1.1 mmol/l) and the calcium serum level is normal (2.2 - 2.7 mmol/l).

For risks and side-effects please read the package leaflet and ask your doctor or pharmacist. Protina Pharm. GmbH, D-85737 Ismaning.